Form 4: National Healthcare Corp Director Exercises Options, Adjusts Beneficial Ownership

Director W. Andrew Adams exercised stock options and adjusted his beneficial ownership in National Healthcare Corp on May 7, 2024.

Summary

• On May 7, 2024, W. Andrew Adams, a director of National Healthcare Corp (NHC), exercised options to purchase 7,500 shares of common stock at a price of $77.92 per share.
• This transaction was executed under the company's 2010 Omnibus Equity Incentive Plan.
• Following the transaction, Adams directly owns 262,072 shares of common stock through a revocable living trust and 7,500 options to purchase common stock from each of the 2020, 2021, 2022, and 2023 grants.
• Adams also has indirect ownership of 35,407 shares through the Adams Family Foundation II and 2,307 shares through the Adams Grandchildren's Trust.
• The exercise of these options is exempt from Section 16(b) of the Securities Exchange Act of 1934, according to Rule 16b-3(d).

Sentiment

Score: 6

Explanation: The document is a routine disclosure of an option exercise, which is neither particularly positive nor negative. It reflects standard corporate governance practices.

Positives

• The exercise of options indicates the director's confidence in the company's future performance.
• The transaction was executed under the company's equity incentive plan, aligning the director's interests with those of the shareholders.

Industry Context

Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects. Option exercises are a common form of executive compensation in the healthcare industry.

Comparison to Industry Standards

• Option grants and exercises are standard practice in executive compensation across the healthcare industry.
• Companies like HCA Healthcare and Universal Health Services also utilize stock options as part of their executive compensation packages.
• The specific terms of option grants, such as vesting schedules and exercise prices, can vary based on company performance and industry benchmarks.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it slightly increases the number of outstanding shares.

Key Dates